Trials / Conditions / Neuroendocrine Prostate Cancer
Neuroendocrine Prostate Cancer
5 registered clinical trials studyying Neuroendocrine Prostate Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727 | Novartis Pharmaceuticals | Phase 1 |
| Not Yet Recruiting | Study of ZG006 in Participants With Neuroendocrine Prostate Cancer NCT07024277 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Phase 2 |
| Completed | A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer NCT04702737 | Amgen | Phase 1 |
| Terminated | Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors NCT02709889 | AbbVie | Phase 1 / Phase 2 |
| Completed | A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer NCT01799278 | Weill Medical College of Cornell University | Phase 2 |